LEPTOSPIRA SP - ANVISA Registration 10071770832

Access comprehensive regulatory information for LEPTOSPIRA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10071770832 and manufactured by manufacturer not specified. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Apr 18, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including INSTITUT VIRION\SERION GMBH, HANGZHOU ALLTEST BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10071770832
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770832
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

LEPTOSPIRA IgM ELISA
Risk Class III

Registration Details

10071770832

25351788857201411

50248780000161

Company Information

Dates and Status

Mar 30, 2015

18/04/2026

09/18/2025 19:00:01

LEPTOSPIRA IgM ELISA
Risk Class III

Registration Details

10071770832

25351788857201411

50248780000161

Company Information

South Korea
PT: CORÉIA DO SUL

Dates and Status

Mar 30, 2015

18/04/2026

09/18/2025 19:00:01